384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy

• Amy Hall,
• Shari Pilon-Thomas,
• John Mullinax,
• MacLean Hall,
• Allison Richards,
• Amod Sarnaik,
• Jamie Teer,
• Patrick Innamarato,
• Matthew Beatty,
• Jonathan Hensel,
• Holly Branthoover,
• Alex Alfaro,
• Jeani Rich,
• Jim Bender,
• Jake Ceccarelli,
• TJ Langer

Affiliations

Amy Hall

International Agency for Research on Cancer, Lyon, France

Shari Pilon-Thomas

Moffitt Cancer Center and The University of South Florida, Tampa, FL, USA

John Mullinax

Moffitt Cancer Center and The University of South Florida, Tampa, FL, USA

MacLean Hall

Aff153 grid.468198.a0000000098915233H. Lee Moffitt Cancer Center Tampa FL USA

Allison Richards

Aff153 grid.468198.a0000000098915233H. Lee Moffitt Cancer Center Tampa FL USA

Amod Sarnaik

1H. Lee Moffitt Cancer Center, Tampa, FL, USA

Jamie Teer

1Moffitt Cancer Center, Tampa, FL, USA

Patrick Innamarato

Moffitt Cancer Center and The University of South Florida, Tampa, FL, USA

Matthew Beatty

Moffitt Cancer Center and The University of South Florida, Tampa, FL, USA

Jonathan Hensel

H. Lee Moffitt Cancer Center, Tampa, FL, USA

Holly Branthoover

1Moffitt Cancer Center, Tampa, FL, USA

Alex Alfaro

1Moffitt Cancer Center, Tampa, FL, USA

Jeani Rich

1Moffitt Cancer Center, Tampa, FL, USA

Jim Bender

2Turnstone Biologics, New York, NY, USA

Jake Ceccarelli

2Turnstone Biologics, New York, NY, USA

TJ Langer

2Turnstone Biologics, New York, NY, USA